FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043178 [Registered on: 10/06/2022] Trial Registered Prospectively
Last Modified On: 04/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   effect of locally delivered drug after extraction to control pain and infection without taking oral tablets 
Scientific Title of Study   Efficacy of local drug delivery system in minimizing the systemic administration of postoperative medication 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chandra Kiran Venkata Sai Pathuri 
Designation  post graduate student 
Affiliation  sibar institute of dental sciences 
Address  department of oral and maxillofacial surgery, sibar institute of dental sciences, takellapadu, guntur

Guntur
ANDHRA PRADESH
522509
India 
Phone  7658900210  
Fax    
Email  drpckvsai@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chandra Kiran Venkata Sai Pathuri 
Designation  post graduate student 
Affiliation  sibar institute of dental sciences 
Address  department of oral and maxillofacial surgery, sibar institute of dental sciences, takellapadu, guntur


ANDHRA PRADESH
522509
India 
Phone  7658900210  
Fax    
Email  drpckvsai@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Chandra Kiran Venkata Sai Pathuri 
Designation  post graduate student 
Affiliation  sibar institute of dental sciences 
Address  department of oral and maxillofacial surgery, sibar institute of dental sciences, takellapadu, guntur


ANDHRA PRADESH
522509
India 
Phone  7658900210  
Fax    
Email  drpckvsai@gmail.com  
 
Source of Monetary or Material Support  
sibar institute of dental sciences 
 
Primary Sponsor  
Name  chandra kiran Venkata sai pathuri 
Address  sibar institute of dental sciences, takkellapadu, Guntur district 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anand Vijay somuri  sibar institute of dental sciences  department of oral and maxillofacial surgery, room no: 3, takkellapadu
Guntur
ANDHRA PRADESH 
7658900210

dr.anandvijay@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-SIBAR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K049||Other and unspecified diseases ofpulp and periapical tissues,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  medicated microspheres  Microspheres containing amoxicillin and clavulanic acid – 625 mg 2) Microspheres containing acelofenac – 100mg duration/ observation period is 3 days for acelofenac duration/observation period is 3 days for amoxicillin  
Comparator Agent  oral tablets  Oral amoxicillin and clavulanic acid tablets – 625 mg as per regimen Oral acelofenac – 100 mg as per regimen duration/observation period if for 7 days for both tablets 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA 1 and ASA 2 individuals between 20-60 years of age.
Individuals tolerant to NSAID’s.
Individuals with no known pencillin allergy
 
 
ExclusionCriteria 
Details  Patients who are on analgesics or sedatives for any other systemic issues
Patients who are on antibiotics for any other systemic issues 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
pain - will be assessed by Numerical Rating Scale(NRS)   1st day, 2nd day and 3rd day 
 
Secondary Outcome  
Outcome  TimePoints 
infection - will be assessed using Landry et al healing index by clinical examination  7th day 
comfort - will be assessed using comfort rating scale  1st, 2nd and 3rd day 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/06/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title: â€œEfficacy of local drug delivery system in minimizing the

systemic administration of postoperative medication”

Principal Investigator: Chandra Kiran Venkata Sai Pathuri Department of Oral and Maxillofacial Surgery

Sibar institute of dental sciences, Guntur

Introduction:

Extractions are most common surgical procedures performed by oral and maxillofacial surgeon.[2]
The premise of successful exodontic surgical treatment is based not only on the correct operative technique but also on the prevention and management of postoperative complications.[3]
Common post-operative complications associated with extraction are pain and infection.[2]
Post extraction pain has often been a nemesis for dental surgeon [3]

According to the International Association for the Study of Pain, pain is defined as “Unpleasant sensory and emotional experience associated with actual or potential tissue damage.” Pain after extraction is a common complication. Pain is common body response to wound anywhere in the body. Post extraction pain occurs in extraction wound as it is not different from other body wound, and this pain result from the inflammation at the site of extraction which is a part of normal wound healing. [1]

page2image34332544

.2

Antibiotics are commonly administered whether oral parenteral to reduce the chances of postoperative infection of extraction site. Pencillins are most frequently used antibiotics for preventing socket infection[2]

NSAIDS are most preferred class of drugs prescribed post treatment and administration of such drugs through oral route has increased risk of varying adverse effects [4]

There are various routes of drug administration, but the main aim is to relieve pain, improve comfort and promote wound healing in a way which is best tolerated by the patient. Oral and parenteral are the commonly used routes of drug administration. Both oral & parenteral routes are associated with significant no: of problems like patient compliance, gastrointestinal disturbance and pain.[2]

Therefore, local drug delivery have been developed as a painless, non-invasive and effective route of drug delivery system ad takes precedence over other routes in terms of compliance.

Local drug delivery at the site of surgery has potential of having advantages of antibiotic and NSAIDS without the major short comings of oral/parenteral administration. The zero- order release kinetics of antibiotics from local delivery systems may be very attractive to prevent development of antibiotic resistance[2]

Local drug delivery route is preferred over other routes as

It avoids the first-pass metabolism, thereby increasing the bioavailability of the drug, with sustained release into the blood

Reduces the gastro-intestinal adverse effects

Relieves the pain while administration

Also enhances ease of application, patient’s compliance and comfort.

And also promotes better wound healing with minimal dose of drug.

The purpose of the study is to evaluate the efficacy of local drug delivery as an effective route of drug administration which enhances patient’s compliance and with no additional adverse effects when compared to conventional modes of administration.

REVIEW OF LITERATURE:

Vinay patil et al (2021) conducted a comparative prospective study to evaluate the effects of intraoperative placement of tetracycline, tetracycline + gelatin sponge and placebo on postoperative pain after mandibular molar extraction and concluded that tetracycline and gelatin sponge intrasocket placement provides a good substitute to the prolong use of analgesics and as a good adjuvant in reducing pain in the first few days after routine dental extraction.

Dinesh verma et al (2021) conducted a split mouth randomized clinical trial study to evaluate the effectiveness of amoxicillin and clavulanic acid impregnated plaster of paris beads for prevention of infection of third molar extraction sockets and concluded that amoxicillin with clavulanic acid impregnated pop beads appears to be as effective as oral regimen for prevention of socket infection

Ajay k Pillai et al (2021) conducted a study to evaluate the effect of platelet rich fibrin (PRF) gel as vehicle for delivery of diclofenac sodium following transalveolar extraction of impacted mandibular third molar. In experimental group PRF gel with diclofenac sodium was placed in extraction socket. The clinical parameters especially the postoperative pain, swelling, interincisial distance, wound dehiscence, dry socket, soft tissue healing and infection which were assessed on 1st , 3rd and 7th day following surgical disimpaction and concluded that the use of simple, cost-effective method of autologous PRP gel as vehicle to localised deliver diclofenac sodium may be beneficial to enhance the wound healing process, promotes bone regeneration and reduced pain.

Karthik kp et al (2020) conducted a study to compare anti-inflammatory properties of ibuprofen using two drug delivery systems after third molar surgery using chitosan microspheres as a carrier for local drug delivery in to third molar socket and through the oral route and concluded that ibuprofen incorporated chitosan based microspheres had comparatively better analgesic and anti-inflammatory properties with drastic reduction in pain, swelling, trismus and also had a reliable wound healing property when compared with orallyadministered ibuprofen after mandibular third molar surgery

Suzuki T et al (2018conducted a randomized, single blind, dose response, controlled, clinical study to evaluate the efficacy, safety and appropriate dose of the sustained-release lidocaine sheet for pain following tooth extraction on a total of 94 patients and concluded that administration of sustained release lidocaine sheet at 100mg may have clinical therapeutic potential for pain relief following tooth extraction.

AIMS AND OBJECTIVES:

  • AIM: To assess and compare the efficacy of local drug delivery

    and systemic drug delivery following dental extractions

    Objectives:

    a)To assess pain between study and control groups

    1. b)  To assess comfort between study and control group

    2. c)  To assess wound healing between study and control group

    3. d)  To compare pain, comfort and wound healing between two groups

      Materials & Methods:

      The study will be conducted on outpatients reporting to the department of oral and maxillofacial surgery, Sibar Institute of Dental Sciences,

      Takkellapadu for dental extractions.
      Study design: A triple-blinded randomized comparative study Sampling technique: Simple random sampling.
      Total sample size: 140 (70 in each group)

      Sample size calculation:

      Software used: G*power 3.1.9.2 

      Effect size = 0.5
      αerror = 0.05
      Power = 0.80

      Allocation = 1:1
      Total sample size calculated=128(64ineachgroup) 

      Loss of sample = 10%

      Statistical analysis:

      1. Descriptive statistics

      2. Independent ‘t’ test

      3. Repeated measures of ANOVA with posthoc tukey

        test

      4. Chi-square test

      Materials used:

      1. 1)  Microspheres containing amoxicillin and clavulanic acid – 625 mg

      2. 2)  Microspheres containing acelofenac – 100mg

      3. 3)  Placebo – microspheres without any medication

      4. 4)  Oral placebo – tablets without any medication

      5. 5)  Oral amoxicillin and clavulanic acid tablets – 625 mg

        as per regimen

      6. 6)  Oral acelofenac – 100 mg as per regimen

        Inclusion criteria:

        ASA 1 and ASA 2 individuals between 20-60 years of age.

        Individuals tolerant to NSAID’s.

        Individuals with no known pencillin allergy

        Exclusion criteria:

        • Patients who are on analgesics or sedatives for any other systemic issues

          Patients who are on antibiotics for any other systemic issues

          Procedure:

          Patients reporting to the department of oral and maxillofacial surgery during the study period for dental extractions are included.

          All the participants will be informed about the study and a written informed consent is obtained from all of them.

          The participants will be randomized into study and control groups using lottery method. Randomization and allocation concealment will be done by the recruiter and a unique ID is generated for each participant at the same time. All the procedures will be done by the same surgeon to avoid operator bias. After the procedure, a pre- written prescription is handed over to the participants of respective groups, so that the investigator is kept blinded.

          The pre-written prescription includes medicated microspheres and tablets (placebo) for the experimental group while it includes oral tablets of antibiotic, analgesic and placebo microsphere for the control group to maintain participant blinding. Rescue analgesics are also given and the patient is advised to take them only on demand.

          After the procedure, the patient will be given either medicated microspheres or oral tablets as per recommended regimen along with their respective placebos included.

          The parameters recorded are pain and discomfort on day 1, day 2 and day 3 using Numerical Rating Scale and Comfort Scale.And wound healing on day 7 using Landry et al Healing Index. The adverse effects are also noted, if any. Additionally, the number of rescue analgesics consumed and their frequency of cosumption will also be noted.

          Follow up for assessment of parameters is done over a telephone call by the investigator using investigator administered self- rated pain scale.

          Patient is recalled for a review after 7 days.

          All the observations will be recorded, tabulated and analysed statistically. The statistical analyser will be provided only with the recorded data without revealing which data belongs to the study group, thereby blinding the analyser.

          Blinding is maintained as long as possible throughout the study and analysis.

          The participant and the biostatistician are blinded through out the study and the investigator unveils the data for inference purpose, only after the results are given by the biostatistician or the statistical analyser.

        • SALIENT FEATURES OF THE STUDY DESIGN:

          Allotment of unique ID for each participant.
           A Written informed consent for participation. Randomization into study and control groups. Allocation concealment.
           Triple Blinding.

          Potential Risks and Benefits:

          Risks: No risks involvedBenefits:

          1. Ease of administration.

          2. Longer duration of action when compared to other

            conventional routes.

          3. Flexible route of drug administration

          4. Improved patient compliance and comfort.

          References:

          1. Patil V, Ramaraj PN, Sharma M, Singh R, George A, Roy B. Effects of intraoperative placement of tetracycline, tetracycline + gelatin sponge, and placebo on postoperative pain after mandibular molar extraction: A comparative prospective study. Natl J Maxillofac Surg. 2021;12(2):211–8.

          1. Verma DK, Bansal S, Pahari KC. Can Amoxicillin and Clavulanic Acid Impregnated Plaster of Paris Beads Serve as an Effective Alternative to Systemic Antibiotics for Third Molar Surgeries? A Split Mouth Randomized Clinical Trial. J Maxillofac Oral Surg [Internet]. 2021 Jul 23 [cited 2022 Feb 23];

          2. Pillai AK, Thomas S, Seth S, Jain N, Chobey A. Platelet Rich Fibrin (PRF) Gel as Efficient Vehicle for Local Drug Delivery in Minor Oral Surgical Defects. :7.

          3. Kp K, R B. Evaluation and comparison of anti-inflammatory properties of ibuprofen using two drug delivery systems after third molar surgery: using chitosan microspheres as a carrier for local drug delivery in to the third molar socket and through the oral route. Br J Oral Maxillofac Surg. 2021 Feb;59(2):191– 6.

          4. Suzuki T, Kosugi K, Suto T, Tobe M, Tabata Y, Yokoo S, et al. Sustained-release lidocaine sheet for pain following tooth extraction: A randomized, single-blind, dose-response, controlled, clinical study of efficacy and safety. PLoS One. 2018 Jul 2;13(7):e0200059.

 
Close